BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth strategies. Through this partnership, BGLC plans to leverage ML Tech’s ...
Medical technology company BioNexus Gene Lab Corp. BGLC announced the adoption of Ethereum ETH/USD as a treasury reserve asset on Wednesday, following the cryptocurrency’s inclusion in the U.S ...
KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...
KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...
Healthcare technology company BioNexus Gene Lab has formally approved Ethereum as its primary treasury asset, a Wednesday announcement read.The move marks a strategic shift in the company's ...
KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...
BioNexus Gene Lab Corp. (BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its Board of Directors has formally approved the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback